Skip to content

LGND

Ligand Pharmaceuticals Incorporated

Revenue to net income

Key figures

MetricLast 12 months5-year CAGR
Revenue$254M+10.4%
Gross profit$277M+13.7%
Operating income$24M+1.8%
Net income$51M—
EPS$2.21—
Free cash flow$91M−0.5%